← Back to Search

Telemedicine for Gallbladder Disease

N/A
Recruiting
Led By Rachel Kelz, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will examine how social issues affect Gallbladder Disease outcomes and whether telemedicine consultation can reduce disparities in care.

Who is the study for?
This trial is for adults over 18 with gallbladder disease who belong to a racial or ethnic minority, speak limited English, live in low-income areas, or are underinsured. They must have been seen by a primary care provider or discharged from an emergency department between February and June 2023.Check my eligibility
What is being tested?
The study compares telemedicine consultations with traditional in-person doctor visits before gallbladder surgery. It aims to determine if telemedicine can improve surgical outcomes and reduce disparities among socially vulnerable patients.See study design
What are the potential side effects?
Since the interventions involve consultation methods rather than medications, typical drug side effects aren't expected. However, there may be differences in satisfaction or understanding of medical advice between telemedicine and traditional care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cholecystectomy Surgical Outcome
Secondary outcome measures
Completion of Consultation
Cost
Effect of Consultation on Surgical Outcome.
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine ConsultationExperimental Treatment1 Intervention
Patient will schedule a Telemedicine Consultation in place of traditional in-person visit.
Group II: Traditional In-Person CareActive Control1 Intervention
Patient will schedule a traditional in-person visit as per usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telemedicine Consultation
2020
N/A
~100

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,993 Previous Clinical Trials
42,875,513 Total Patients Enrolled
Leonard Davis Institute of Health EconomicsUNKNOWN
3 Previous Clinical Trials
369 Total Patients Enrolled
Rachel Kelz, MDPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment still have openings for participants?

"As indicated on clinicaltrials.gov, this medical research is currently looking for participants to join the trial. The investigation was initially posted online February 16th of 2023 and has seen its most recent update as of February 22nd of that same year."

Answered by AI

What is the upper limit of participants for this experiment?

"Affirmative. Clinicaltrials.gov proclaims that this clinical research is actively enrolling participants, which it began to do on February 16th of 2023 and most recently updated the soliciting information by February 22nd of 2023. 50 patients are needed at a single medical centre for the trial's completion."

Answered by AI
~9 spots leftby Jun 2024